Orphan designation: Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4 Treatment of ovarian cancer, 19/03/2015 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 October 2024 - 8:00

Orphan designation: Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4 Treatment of ovarian cancer, 19/03/2015 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-15-1458

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters